Back to all studies
RecruitingNCT07053345

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

This recruiting study focuses on depression and currently lists sites or participation links in South Korea.

DepressionOtherFrom 18 Years to 64 Years
In plain English

Key information made simple

This study exists to explore whether the medication Esketamine could improve care and understanding. Researchers are trying to understand what the medication Esketamine could change in day-to-day care and decision-making. For people living with Depression, the gap between what sounds good on paper and what works in daily life is often important. If the findings are useful, they could help future care become more targeted, practical, and easier to trust. Taking part helps build the evidence that can improve understanding and care for others over time.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including Cha Ilsan Medical Center in Goyang Si Gyeonggi Do, Wonkwang University Hospital in Iksan, and Kangbuk Samsung Hospital in Seoul. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis, while common reasons not to take part include other factors that could make participation unsuitable. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Interested?

Check my eligibility

Study reference: NCT07053345. Your email is the only field you need to provide here.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in South Korea.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com